(Q30318389)

17 June 2017

title

Simultaneous medullary and papillary thyroid cancer: a novel entity? (English)

1 reference

17 June 2017

main subject

papillary thyroid cancer

1 reference

2

Henning Dralle

1 reference

17 June 2017

Andreas Machens

1

1 reference

17 June 2017

publication date

28 May 2011

1 reference

Annals of Surgical Oncology

17 June 2017

published in

1 reference

17 June 2017

volume

19

1 reference

17 June 2017

issue

1

1 reference

17 June 2017

page(s)

37-44

1 reference

Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Sporadic hypercalcitoninemia: clinical and therapeutic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Familial prevalence and age of RET germline mutations: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1795-Z

10.1245/S10434-011-1795-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

17 June 2017

1030991297

0 references

Fatcat ID

release_w4iooxkh5zaj3e2yc74qeh5iyy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w4iooxkh5zaj3e2yc74qeh5iyy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference